ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645317; 2) Community: the network communities that were significantly associated with the response to NSC 645317; 3) Molecule: the relationships between components within communities and NSC 645317; 4) MDR: the compounds that were significantly associated with the NSC 645317.

NSC Compound Enrichment Correlation
NSC 746928 Null 0.0306776553926119 0.43050971
NSC 749862 3-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0306776553926119 0.18136324
NSC 752365 2-[6-(4-Hydroxy-3-methoxy-benzylamino)-hexyl]-benzo[de]isoquinoline-1,3-dione para toluen sulphonate 0.0306776553926119 0.20183446
NSC 754088 7-(3-nitro-4-methoxybenzyl)-6-(3,4,5-trimethoxyphenyl)-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole 0.0306776553926119 0.27141682
NSC 111533 Methoxycamptothecin 0.0312262198176279 0.27773518
NSC 205862 Null 0.0312262198176279 0.054383654
NSC 292596 Null 0.0312262198176279 0.023814169
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0312262198176279 -0.023275509
NSC 610459 Camptothecin Derivative 0.0312262198176279 0.32228427
NSC 645852 Null 0.0312262198176281 0.51552389
Total:127  Current:97    [First] [Prev] [Next] [Last]